HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

48.440

-0.700-1.42%

Volume:7.71M

Turnover:381.01M

Market Cap:321.50B

PE:35.07

High:51.000

Open:49.740

Low:48.280

Close:49.140

52wk High:91.880

52wk Low:43.020

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:1.56

T/O Rate:2.99%

Dividend:0.23

Dividend Rate:0.48%

EPS(LYR):1.381

ROE:12.46%

ROA:7.02%

PB:4.26

PE(LYR):35.07

PS:8.77

Loading ...

Overview Company News Filings

Hengrui Pharma Licenses Oral GLP-1/GIP Weight-Loss Drug to Novo Nordisk in Deal Worth Up to $2.6 Billion

China's Hengrui Inks up to $2.6 Billion Deal with Novo Nordisk for Obesity Drug

Hengrui Pharma and Novo Nordisk Sign Licensing Agreement for HRS-1596 Project

Hengrui Pharma Inks Up to USD 2.60 Billion Global Licence Deal with Novo Nordisk for Oral GLP-1/GIP Agonist HRS-1596

Bulletin Express

Jiangsu Hengrui Pharmaceuticals - Entering into License Agreement for Hrs-1596 with Novo Nordisk a/S

THOMSON REUTERS

Jiangsu Hengrui Pharmaceuticals - Potential Total Value of Agreement up to $2.6 Bln Contingent on Achievement of Applicable Development, Others

THOMSON REUTERS

Jiangsu Hengrui Pharmaceuticals - Dedal Includes $300 Mln Upfront Payment

THOMSON REUTERS

Jiangsu Hengrui Pharmaceuticals - Co Also Eligible to Receive Royalties Based on Net Sales of Hrs-1596 Within Licensed Territory

THOMSON REUTERS

Movement Alert｜HENGRUI PHARMA Rises 3.57% in Regular Trading, Multiple Global Institutions Accumulate Shares Amid Accelerated Drug Approvals

Blackrock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.32%, Says HKEX

UBS Group Ag's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 5.23% on Sept 21 from 4.43% - HKEX

THOMSON REUTERS

HENGRUI PHARMA: UBS Group AG Acquires Shares, Long Position Rises to 5.23%

HENGRUI PHARMA: BlackRock, Inc. Acquires Shares, Long Position Rises to 7.32%

HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 6.7%

HENGRUI PHARMA: GIC Private Limited Disposes of Shares, Long Position Falls to 16.92%

Movement Alert｜HENGRUI PHARMA Falls 3.01% in Regular Trading, Pharmaceuticals Sector Under Broad Selling Pressure

HENGRUI PHARMA Spends RMB 11.37 Million Buying Back 250,000 A-Shares on September 23

Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approvals for Ten Drug Candidates

Hengrui Pharma Gets Clinical Trial Approval for Chronic Kidney Disease Drug

MT Newswires Live

Hengrui Pharmaceuticals Gets China Approval for Tumor Drug Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/01276/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":48.44,"timestamp":1791446897003,"preClose":49.14,"halted":0,"volume":7707759,"delay":0,"changeRate":-0.014245014245014303,"floatShares":258000000,"shares":6637000000,"eps":1.3813922719568084,"marketStatus":"Closed","change":-0.7,"latestTime":"10-08 16:08:17","open":49.74,"high":51,"low":48.28,"amount":381006025,"amplitude":0.055352,"askPrice":48.44,"askSize":30800,"bidPrice":48.4,"bidSize":200,"shortable":3,"etf":0,"ttmEps":1.3622986211469648,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":5,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":49.14,"dividendRate":0.004829,"openAndCloseTimeList":[[1791423000000,1791432000000],[1791435600000,1791446400000]],"volumeRatio":1.556397,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":47.01,"timestamp":1791442800000,"preClose":47.2,"halted":0,"volume":77344000,"delay":0,"premium":"-11.98"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.381392,"volumeRatio":1.556397,"shares":6637000000,"dividePrice":0.234134,"high":51,"amplitude":0.055352,"preClose":49.14,"low":48.28,"week52Low":43.02,"pbRate":"4.26","psRate":"8.77","week52High":91.88,"institutionHeld":0,"latestPrice":48.44,"committee":-0.987097,"eps":1.3813922719568084,"divideRate":0.004833,"volume":7707759,"delay":0,"ttmEps":1.3622986211469648,"open":49.74,"prevYearClose":71.002,"prevWeekClose":49.66,"prevMonthClose":50.2,"prevQuarterClose":50.2,"fiveDayClose":50.2,"twentyDayClose":45.94,"sixtyDayClose":58.45,"earningDate":1793116800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1793151000000,"name":null,"time":"","dateTimestamp":1793116800000,"actualEps":null},{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-10-07","current":35.557549,"percent":0.138235,"low":36.382401,"twenty":43.078413,"median":51.356483,"eighty":56.807294,"high":65.582363,"avg":50.578041,"sd":7.710556,"marketCap":364150510612.46},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13},{"date":"2026-09-04","current":39.220129,"twenty":44.050964,"median":51.771686,"eighty":57.152374,"marketCap":353565883607.49},{"date":"2026-09-11","current":36.382401,"twenty":43.912617,"median":51.717719,"eighty":57.022157,"marketCap":328426636361.34},{"date":"2026-09-18","current":37.472943,"twenty":43.707258,"median":51.677141,"eighty":56.974512,"marketCap":338713028678.65},{"date":"2026-09-25","current":38.226655,"twenty":43.43262,"median":51.617827,"eighty":56.891919,"marketCap":344867204477.93},{"date":"2026-10-02","current":40.279147,"twenty":43.172598,"median":51.438629,"eighty":56.828798,"marketCap":363767175425.28},{"date":"2026-10-07","current":40.264098,"twenty":43.078413,"median":51.356483,"eighty":56.807294,"marketCap":364150510612.46}],"updateTime":1791452384829},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1120980647","title":"Hengrui Pharma Licenses Oral GLP-1/GIP Weight-Loss Drug to Novo Nordisk in Deal Worth Up to $2.6 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1120980647","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120980647?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:28","pubTimestamp":1790659697,"startTime":"0","endTime":"0","summary":"Hengrui Pharma has licensed its self-developed oral GLP-1/GIP dual receptor agonist HRS-1596 to global weight-loss drug leader Novo Nordisk, with a potential total deal value of up to $2.6 billion,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0196","LU2097828714.EUR","BK1191","LU2488822045.USD","LU1064130708.USD","LU1969619763.USD","JDOC","01276","BK0060","LU2097828805.USD","LU2328871848.SGD","LU0359201885.HKD","LU2543165471.USD","LU1064131003.USD","LU1997245177.USD","LU2097828474.EUR","LU2097828557.USD","LU1328615791.USD","LU1997244956.HKD","LU0405327148.USD","BK0239","600276","LU1255011170.USD","LU2495084118.USD","LU1820825898.SGD","LU1655091616.SGD","LU0359202008.SGD","BGIA","LU2580892862.HKD","LU1023057109.AUD","LU2097828631.EUR","LU1781817850.SGD","BK0183","BK0188","LU0359201612.USD","LU1146622755.USD","LU2289578879.USD","LU2580892789.USD","LU1580142542.USD","LU0405327494.USD","LU2148510915.USD","LU1997245094.SGD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671298568","title":"China's Hengrui Inks up to $2.6 Billion Deal with Novo Nordisk for Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2671298568","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671298568?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:10","pubTimestamp":1790658607,"startTime":"0","endTime":"0","summary":"Sept 29 (Reuters) - Jiangsu $Hengrui Pharmaceuticals(01276)$, China's largest drugmaker by ‌market value, said on Tuesday it will license global rights to ⁠its weight-management drug HRS-1596 to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL4N45L0BV:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China's Hengrui Inks up to $2.6 Billion Deal with Novo Nordisk for Obesity Drug","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0239","LU2488822045.USD","LU2328871848.SGD","LU2495084118.USD","LU2148510915.USD","BK0196","LU1969619763.USD","600276","LU2097828557.USD","LU2580892862.HKD","LU0405327494.USD","LU1781817850.SGD","LU1064130708.USD","NVOH","LU2289578879.USD","LU1820825898.SGD","NVOX","LU1328615791.USD","LU1064131003.USD","BK0183","LU1655091616.SGD","LU2097828474.EUR","LU2580892789.USD","LU1255011170.USD","LU1997245177.USD","LU2097828714.EUR","NVO","LU2097828631.EUR","NVOC","BK0012","01276","LU1146622755.USD","BK0188","LU0405327148.USD","LU1580142542.USD","BK0028","LU1997244956.HKD","LU1997245094.SGD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107831327","title":"Hengrui Pharma and Novo Nordisk Sign Licensing Agreement for HRS-1596 Project","url":"https://stock-news.laohu8.com/highlight/detail?id=1107831327","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107831327?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:49","pubTimestamp":1790657347,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (600276.SH) announced that the company has entered into an agreement with Novo Nordisk A/S to license its potential once-weekly oral GLP-1 and GIP dual receptor agonist HRS-1596 to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2580892862.HKD","LU1064131003.USD","LU2495084118.USD","NVOX","BK0183","OZEM","LU2097828714.EUR","LU2328871848.SGD","01276","BK4007","NVOH","BK4599","LU1328615791.USD","LU2289578879.USD","NVO","LU1255011170.USD","LU1997245094.SGD","LU2097828557.USD","LU2097828474.EUR","NVOC","BK0188","LU0405327148.USD","LU2148510915.USD","BK0196","LU1820825898.SGD","LU1781817850.SGD","LU0405327494.USD","IE00BKVL7J92.USD","LU1997245177.USD","LU0154236417.USD","PPH","LU2097828805.USD","LU2580892789.USD","LU1093756325.SGD","LU1580142542.USD","LU1655091616.SGD","BK4585","THNR","LU1997244956.HKD","BK4588","LU1969619763.USD","BK0028","LU2488822045.USD","600276","BK4532","BK0060","LU2097828631.EUR","LU1146622755.USD","LU1064130708.USD","BK0239","BK0012","IE00BZ1G4Q59.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129213065","title":"Hengrui Pharma Inks Up to USD 2.60 Billion Global Licence Deal with Novo Nordisk for Oral GLP-1/GIP Agonist HRS-1596","url":"https://stock-news.laohu8.com/highlight/detail?id=1129213065","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129213065?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:42","pubTimestamp":1790656952,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) has signed a licence agreement with Novo Nordisk A/S granting Novo exclusive rights to develop, manufacture and commercialise the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671260728","title":"Jiangsu Hengrui Pharmaceuticals - Entering into License Agreement for Hrs-1596 with Novo Nordisk a/S","url":"https://stock-news.laohu8.com/highlight/detail?id=2671260728","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671260728?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:28","pubTimestamp":1790656131,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L00A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1781817850.SGD","BK0183","BK0196","LU1064130708.USD","LU1969619763.USD","LU1997245177.USD","LU2097828805.USD","LU0405327148.USD","LU1146622755.USD","LU1997244956.HKD","LU2328871848.SGD","BK1191","LU2488822045.USD","LU1580142542.USD","LU2580892789.USD","LU0359201612.USD","LU2495084118.USD","LU2097828474.EUR","LU0359201885.HKD","LU2097828557.USD","LU0359202008.SGD","01276","BK0239","LU0405327494.USD","LU1023057109.AUD","LU1255011170.USD","LU2097828631.EUR","BK0028","LU1655091616.SGD","LU2148510915.USD","600276","LU2097828714.EUR","BK0188","BK0012","BK0060","LU2289578879.USD","LU2580892862.HKD","LU1064131003.USD","LU1328615791.USD","LU2543165471.USD","LU1820825898.SGD","LU1997245094.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671260724","title":"Jiangsu Hengrui Pharmaceuticals - Potential Total Value of Agreement up to $2.6 Bln Contingent on Achievement of Applicable Development, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2671260724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671260724?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:28","pubTimestamp":1790656131,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L00A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1255011170.USD","LU0405327494.USD","LU2328871848.SGD","LU2488822045.USD","LU1997244956.HKD","LU0405327148.USD","BK1191","LU2097828631.EUR","LU0359202008.SGD","LU2580892862.HKD","LU2543165471.USD","LU1064131003.USD","600276","LU1146622755.USD","LU1064130708.USD","BK0012","BK0239","LU1023057109.AUD","BK0028","BK0183","LU0359201612.USD","LU2097828557.USD","LU2097828805.USD","BK0188","LU2148510915.USD","01276","LU1781817850.SGD","LU2097828474.EUR","LU1997245094.SGD","LU0359201885.HKD","LU1969619763.USD","BK0060","LU1328615791.USD","LU2289578879.USD","LU2580892789.USD","LU1820825898.SGD","LU2097828714.EUR","BK0196","LU1997245177.USD","LU1580142542.USD","LU2495084118.USD","LU1655091616.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671260048","title":"Jiangsu Hengrui Pharmaceuticals - Dedal Includes $300 Mln Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2671260048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671260048?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:28","pubTimestamp":1790656131,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L00A:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1328615791.USD","BK0188","LU1997245177.USD","LU1580142542.USD","LU2097828631.EUR","LU2289578879.USD","LU2580892789.USD","LU1997245094.SGD","LU0405327494.USD","LU2097828714.EUR","LU0359201612.USD","LU1997244956.HKD","BK0239","LU2097828557.USD","LU2495084118.USD","BK0196","LU1255011170.USD","LU1781817850.SGD","LU0359201885.HKD","BK0028","BK1191","LU1146622755.USD","LU0359202008.SGD","BK0012","LU2097828805.USD","LU1969619763.USD","LU2580892862.HKD","LU1064131003.USD","LU2328871848.SGD","LU2097828474.EUR","LU1655091616.SGD","01276","BK0183","BK0060","LU1023057109.AUD","LU1820825898.SGD","LU2543165471.USD","LU0405327148.USD","LU2488822045.USD","600276","LU1064130708.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671126001","title":"Jiangsu Hengrui Pharmaceuticals - Co Also Eligible to Receive Royalties Based on Net Sales of Hrs-1596 Within Licensed Territory","url":"https://stock-news.laohu8.com/highlight/detail?id=2671126001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671126001?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:28","pubTimestamp":1790656131,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L00A:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0405327494.USD","LU2488822045.USD","LU0405327148.USD","LU0359202008.SGD","LU1064130708.USD","BK0028","LU2097828557.USD","01276","600276","LU1655091616.SGD","LU1969619763.USD","LU2097828714.EUR","LU2328871848.SGD","BK0239","LU1997245094.SGD","LU1580142542.USD","LU2097828805.USD","BK0183","LU1820825898.SGD","LU1023057109.AUD","LU2543165471.USD","LU1146622755.USD","LU1997245177.USD","LU2289578879.USD","LU1064131003.USD","LU1997244956.HKD","LU2097828474.EUR","LU2148510915.USD","LU0359201885.HKD","BK0188","LU0359201612.USD","LU2580892789.USD","LU2580892862.HKD","LU1255011170.USD","LU1328615791.USD","LU2097828631.EUR","LU2495084118.USD","LU1781817850.SGD","BK0060","BK0012","BK0196","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172293230","title":"Movement Alert｜HENGRUI PHARMA Rises 3.57% in Regular Trading, Multiple Global Institutions Accumulate Shares Amid Accelerated Drug Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=1172293230","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172293230?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:56","pubTimestamp":1790646971,"startTime":"0","endTime":"0","summary":"On September 29, HENGRUI PHARMA rose 3.57% in regular trading, trading at HK$46.1/share, with turnover of HK$34.26 million.The rally was driven by a wave of institutional accumulation from top global...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"UBS and BlackRock Boost Stakes in Hengrui Pharma","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670444684","title":"Blackrock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.32%, Says HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2670444684","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670444684?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:31","pubTimestamp":1790332286,"startTime":"0","endTime":"0","summary":"BRIEF-Blackrock's Long Position In H-Shares Of Jiangsu Hengrui Pharmaceuticals Increases To 7.32%, Says HKEXSept 25 (Reuters)-HKEX:BLACKROCK'S LONG POSITION IN H-SHARES OF JIANGSU HENGRUI PHARMACEUTICALS INCREASES TO 7.32% ON SEPT 22 FROM 6.56%Further company coverage:1276.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1CT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","BK0196","LU2580892789.USD","LU2097828714.EUR","BK1191","BK0028","LU1655091616.SGD","LU2289578879.USD","LU0405327494.USD","LU1781817850.SGD","LU2097828557.USD","LU2543165471.USD","LU1997245177.USD","LU0405327148.USD","BK0188","LU1146622755.USD","LU1328615791.USD","LU1580142542.USD","LU2097828474.EUR","LU2097828805.USD","LU2148510915.USD","BK0239","LU1997245094.SGD","LU1064131003.USD","LU2328871848.SGD","LU2580892862.HKD","BK0012","BK0060","LU0359201885.HKD","LU0359202008.SGD","LU1997244956.HKD","LU2488822045.USD","LU2495084118.USD","600276","LU1820825898.SGD","LU1023057109.AUD","LU0359201612.USD","LU1255011170.USD","LU1969619763.USD","LU2097828631.EUR","BK0183","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670419744","title":"UBS Group Ag's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 5.23% on Sept 21 from 4.43% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2670419744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670419744?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:55","pubTimestamp":1790330133,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2543165471.USD","LU1580142542.USD","BK0196","LU0359201885.HKD","BK0028","BK0239","BK0188","LU1969619763.USD","LU2097828557.USD","BK0012","LU2289578879.USD","LU2580892789.USD","LU2580892862.HKD","LU1255011170.USD","LU2097828805.USD","LU2488822045.USD","01276","LU0359201612.USD","LU0359202008.SGD","LU1146622755.USD","LU2097828631.EUR","LU1820825898.SGD","BK0183","LU2328871848.SGD","LU0405327494.USD","LU1655091616.SGD","BK0060","LU1064130708.USD","LU2148510915.USD","LU2097828474.EUR","LU2495084118.USD","LU0405327148.USD","LU1997245177.USD","LU1997245094.SGD","LU1328615791.USD","BK1191","LU1997244956.HKD","LU1023057109.AUD","LU1781817850.SGD","LU1064131003.USD","600276","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120302430","title":"HENGRUI PHARMA: UBS Group AG Acquires Shares, Long Position Rises to 5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120302430","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120302430?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:15","pubTimestamp":1790327728,"startTime":"0","endTime":"0","summary":"UBS Group AG bought 2.07 million shares of HENGRUI PHARMA on the SEHK open market at an average of HKD 48.8574 per share on September 21, 2026, involving about HKD 100.98 million. This was an...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198751592","title":"HENGRUI PHARMA: BlackRock, Inc. Acquires Shares, Long Position Rises to 7.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198751592","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198751592?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:15","pubTimestamp":1790327719,"startTime":"0","endTime":"0","summary":"On September 22, 2026, BlackRock, Inc. acquired 1.96 million H shares of HENGRUI PHARMA by way of taking a security interest in shares. The transaction was an off-exchange deal with consideration...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182591067","title":"HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 6.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182591067","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182591067?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:37","pubTimestamp":1790242669,"startTime":"0","endTime":"0","summary":"On September 21, 2026, BlackRock, Inc. disposed of 1.82 million H shares of HENGRUI PHARMA (01276) by way of releasing a security interest (non-cash assets) in an off-exchange transaction, reducing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155731676","title":"HENGRUI PHARMA: GIC Private Limited Disposes of Shares, Long Position Falls to 16.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155731676","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155731676?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:19","pubTimestamp":1790241543,"startTime":"0","endTime":"0","summary":"On September 21, 2026, GIC Private Limited sold 214,200 shares of HENGRUI PHARMA (01276) on the SEHK open market at an average of HKD 47.8372 per share, involving about HKD 10.25 million.Prior to the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137502049","title":"Movement Alert｜HENGRUI PHARMA Falls 3.01% in Regular Trading, Pharmaceuticals Sector Under Broad Selling Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1137502049","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137502049?lang=en_us&edition=fundamental","pubTime":"2026-09-24 10:27","pubTimestamp":1790216820,"startTime":"0","endTime":"0","summary":"On September 24, HENGRUI PHARMA fell 3.01% in regular trading, trading at HK$45.80/share, with turnover of approximately HK$37.63 million.The decline was primarily driven by broad-based weakness...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hengrui Pharma Slips as Sector Selloff Hits Drug Stocks","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165450532","title":"HENGRUI PHARMA Spends RMB 11.37 Million Buying Back 250,000 A-Shares on September 23","url":"https://stock-news.laohu8.com/highlight/detail?id=1165450532","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165450532?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:45","pubTimestamp":1790156710,"startTime":"0","endTime":"0","summary":"On September 23, 2026, HENGRUI PHARMA (01276) executed a share repurchase, investing RMB 11.3723 million to buy back 250,000 A-shares. The buyback price ranged between RMB 45.42 and RMB 45.54 per...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","LU1064130708.USD","LU0405327494.USD","LU2148510915.USD","LU2580892789.USD","03188","83188","LU1255011170.USD","LU1580142542.USD","LU1820825898.SGD","LU1969619763.USD","LU1997245094.SGD","LU2097828714.EUR","LU2580892862.HKD","LU1328615791.USD","BK0188","LU2097828805.USD","LU2097828557.USD","LU2328871848.SGD","LU1064131003.USD","03130","LU1997245177.USD","LU2097828631.EUR","399300","83130","600276","BK0196","BK0028","07233","LU1146622755.USD","BK1191","01276","BK1147","LU2543165471.USD","BK0239","159982","LU0405327148.USD","LU1023057109.AUD","LU2097828474.EUR","LU0359201612.USD","LU2495084118.USD","82846","02827","LU2289578879.USD","LU0359201885.HKD","02846","BK0012","LU2488822045.USD","LU1655091616.SGD","LU1997244956.HKD","BK0183","LU0359202008.SGD","LU1781817850.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112810908","title":"Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approvals for Ten Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=1112810908","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112810908?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:42","pubTimestamp":1790152956,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (600276.SH) has announced that it and its subsidiaries recently received Drug Clinical Trial Approval Notices from the National Medical Products...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","BK0188","LU1997245177.USD","LU1580142542.USD","MDTX","LU2097828631.EUR","LU2289578879.USD","LU2580892789.USD","LU1997245094.SGD","LU0405327494.USD","LU2097828714.EUR","LU0359201612.USD","LU1997244956.HKD","BK0239","LU2097828557.USD","PSYK","LU2495084118.USD","BK0196","LU1255011170.USD","LU1781817850.SGD","LU0359201885.HKD","BK0028","BK1191","BMED","LU1146622755.USD","LU0359202008.SGD","BK0012","LU2097828805.USD","LU1969619763.USD","LU2580892862.HKD","LU1064131003.USD","LU2328871848.SGD","IBBQ","LU1655091616.SGD","LU2097828474.EUR","01276","BK0183","BK0060","LU1023057109.AUD","IBBJ","LU1820825898.SGD","LU2543165471.USD","LU0405327148.USD","LU2488822045.USD","600276","LU1064130708.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669190516","title":"Hengrui Pharma Gets Clinical Trial Approval for Chronic Kidney Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2669190516","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669190516?lang=en_us&edition=fundamental","pubTime":"2026-09-22 10:58","pubTimestamp":1790045905,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  and its subsidiary Fujian Shengdi Medicine received clinical trial approval from China's National Medical Products Administration for its HRS-4729 self-developed injection for chronic kidney disease.The drug suppresses appetite, delays gastric emptying, improves insulin sensitivity, breaks down fat, and boosts energy expenditure, according to a Tuesday filing with the Shanghai bourse.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0359202008.SGD","01276","LU1023057109.AUD","LU0359201612.USD","LU2543165471.USD","LU0359201885.HKD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669190378","title":"Hengrui Pharmaceuticals Gets China Approval for Tumor Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669190378","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669190378?lang=en_us&edition=fundamental","pubTime":"2026-09-22 10:52","pubTimestamp":1790045534,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  unit Suzhou Shengdia Biopharmaceutical obtained China's regulatory approval to conduct clinical trials for SHR-4595 injection.The trial will evaluate the biological product's efficacy in treating patients with advanced malignant solid tumors, according to a Monday aftermarket filing with the Shanghai bourse.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2543165471.USD","LU1023057109.AUD","LU0359201885.HKD","LU0359202008.SGD","LU0359201612.USD","01276","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}